Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Report places Bush’s blockage at 95%

CNN reported that the blockage in former President George W. Bush’s coronary artery was “in the ballpark of 95 percent.” He underwent PCI in August, which at the time was criticized as possibly a case of overuse of stenting.

Thumbnail

Jack Lewin takes over as president, CEO of CRF

The Cardiovascular Research Foundation (CRF) has named Jack Lewin, MD, as its president and CEO. He was also appointed to the board of directors.

Experts redefine post-revascularization MI

An expert panel recommended changing the definition of an MI after coronary revascularization to incorporate what the cardiologists defined as a more clinically relevant MI. “We need to make sure that what we measure makes an impact on clinical outcomes,” lead author Issam D. Moussa, MD, explained in an interview with Cardiovascular Business.

Thumbnail

Early statins may lower risk of post-procedure kidney injury

Patients with acute coronary syndrome (ACS) who use rosuvastatin may lower their risk of post-procedure contrast-induced kidney injury, according to a study published online Oct. 9 in Journal of the American College of Cardiology. Significantly fewer patients who took the statin drug developed CI-AKI compared with patients who did not receive the drug.

Greenwich Hospital Auxiliary gives $500,000 to benefit cardiology department

The Greenwich Hospital Auxiliary has made a $500,000 donation to benefit cardiovascular services at Greenwich Hospital. The generous gift was made during the Auxiliary’s 63rd annual meeting on Sept. 30.

Hunterdon Medical Center breaks ground on cardiovascular center

No other health concern affects more people in Hunterdon County than cardiovascular disease.  It is the County’s leading cause of death and its incidence is on the rise due, in part, to the growing number of area residents between the age of 45 and 64 – a time in life in which the onset of cardiovascular disease is most likely to occur.  Hunterdon Medical Center has begun construction on its new Cardiovascular Center. The expansion will centralize all acute care cardiovascular services.

Methodist Mansfield Medical Center achieves Cycle IV Chest Pain center accreditation

Methodist Mansfield Medical Center has received Cycle IV Chest Pain Center Accreditation from the Society of Cardiovascular Patient Care (SCPC), an international not-for-profit organization that focuses on transforming cardiovascular care by assisting facilities in their effort to create communities of excellence that bring together quality, cost and patient satisfaction.

Stent type, timing may not drive outcomes in noncardiac surgeries

It may be time to dust off guideline recommendations on noncardiac surgery for patients who underwent recent coronary stenting, based on findings published online Oct. 7 in JAMA. Researchers cited emergency surgery and advanced cardiac disease, not stent type or antiplatelet issues, as the top determinants of adverse events.   

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.